{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:29:06Z","timestamp":1789014546643,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"15","license":[{"start":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T00:00:00Z","timestamp":1475452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T00:00:00Z","timestamp":1475452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1038\/onc.2016.366","type":"journal-article","created":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T10:09:45Z","timestamp":1475489385000},"page":"2085-2094","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["NPM-ALK phosphorylates WASp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma"],"prefix":"10.1038","volume":"36","author":[{"given":"C A","family":"Murga-Zamalloa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Mendoza-Reinoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A A","family":"Sahasrabuddhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Rolland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S R","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S R P","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A P","family":"Sciallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R A","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Bashur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Elenitoba-Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M S","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,3]]},"reference":[{"key":"BFonc2016366_CR1","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1182\/blood-2007-04-060715","volume":"110","author":"HM Amin","year":"2007","unstructured":"Amin HM, Lai R . Pathobiology of ALK+ anaplastic large-cell lymphoma. Blood 2007; 110: 2259\u20132267.","journal-title":"Blood"},{"key":"BFonc2016366_CR2","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1126\/science.8122112","volume":"263","author":"SW Morris","year":"1994","unstructured":"Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994; 263: 1281\u20131284.","journal-title":"Science"},{"key":"BFonc2016366_CR3","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1128\/MCB.17.4.2312","volume":"17","author":"D Bischof","year":"1997","unstructured":"Bischof D, Pulford K, Mason DY, Morris SW . Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Mol Cell Biol 1997; 17: 2312\u20132325.","journal-title":"Mol Cell Biol"},{"key":"BFonc2016366_CR4","doi-asserted-by":"publisher","first-page":"6951","DOI":"10.1128\/MCB.18.12.6951","volume":"18","author":"RY Bai","year":"1998","unstructured":"Bai RY, Dieter P, Peschel C, Morris SW, Duyster J . Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity. Mol Cell Biol 1998; 18: 6951\u20136961.","journal-title":"Mol Cell Biol"},{"key":"BFonc2016366_CR5","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1038\/onc.2011.542","volume":"31","author":"SR McDonnell","year":"2012","unstructured":"McDonnell SR, Hwang SR, Basrur V, Conlon KP, Fermin D, Wey E et al. NPM-ALK signals through glycogen synthase kinase 3beta to promote oncogenesis. Oncogene 2012; 31: 3733\u20133740.","journal-title":"Oncogene"},{"key":"BFonc2016366_CR6","first-page":"2194","volume":"61","author":"A Slupianek","year":"2001","unstructured":"Slupianek A, Nieborowska-Skorska M, Hoser G, Morrione A, Majewski M, Xue L et al. Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin\/anaplastic lymphoma kinase-mediated lymphomagenesis. Cancer Res 2001; 61: 2194\u20132199.","journal-title":"Cancer Res"},{"key":"BFonc2016366_CR7","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/sj.onc.1205152","volume":"21","author":"A Zamo","year":"2002","unstructured":"Zamo A, Chiarle R, Piva R, Howes J, Fan Y, Chilosi M et al. Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death. Oncogene 2002; 21: 1038\u20131047.","journal-title":"Oncogene"},{"key":"BFonc2016366_CR8","doi-asserted-by":"publisher","first-page":"8899","DOI":"10.1158\/0008-5472.CAN-08-2568","volume":"68","author":"C Ambrogio","year":"2008","unstructured":"Ambrogio C, Voena C, Manazza AD, Martinengo C, Costa C, Kirchhausen T et al. The anaplastic lymphoma kinase controls cell shape and growth of anaplastic large cell lymphoma through Cdc42 activation. Cancer Res 2008; 68: 8899\u20138907.","journal-title":"Cancer Res"},{"key":"BFonc2016366_CR9","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1182\/blood-2005-03-1204","volume":"106","author":"C Ambrogio","year":"2005","unstructured":"Ambrogio C, Voena C, Manazza AD, Piva R, Riera L, Barberis L et al. p130Cas mediates the transforming properties of the anaplastic lymphoma kinase. Blood 2005; 106: 3907\u20133916.","journal-title":"Blood"},{"key":"BFonc2016366_CR10","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1182\/blood-2009-02-204735","volume":"114","author":"MS Lim","year":"2009","unstructured":"Lim MS, Carlson ML, Crockett DK, Fillmore GC, Abbott DR, Elenitoba-Johnson OF et al. The proteomic signature of NPM\/ALK reveals deregulation of multiple cellular pathways. Blood 2009; 114: 1585\u20131595.","journal-title":"Blood"},{"key":"BFonc2016366_CR11","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S1097-2765(02)00728-1","volume":"10","author":"Y Sasahara","year":"2002","unstructured":"Sasahara Y, Rachid R, Byrne MJ, de la Fuente MA, Abraham RT, Ramesh N et al. Mechanism of recruitment of WASP to the immunological synapse and of its activation following TCR ligation. Mol Cell 2002; 10: 1269\u20131281.","journal-title":"Mol Cell"},{"key":"BFonc2016366_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1074-7613(02)00360-6","volume":"17","author":"L Dupre","year":"2002","unstructured":"Dupre L, Aiuti A, Trifari S, Martino S, Saracco P, Bordignon C et al. Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. Immunity 2002; 17: 157\u2013166.","journal-title":"Immunity"},{"key":"BFonc2016366_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1046\/j.0818-9641.2002.01147.x","volume":"81","author":"S Linder","year":"2003","unstructured":"Linder S, Wintergerst U, Bender-Gotze C, Schwarz K, Pannicke U, Aepfelbacher M . Macrophages of patients with X-linked thrombocytopenia display an attenuated Wiskott-Aldrich syndrome phenotype. Immunol Cell Biol 2003; 81: 130\u2013136.","journal-title":"Immunol Cell Biol"},{"key":"BFonc2016366_CR14","doi-asserted-by":"publisher","first-page":"9648","DOI":"10.1073\/pnas.96.17.9648","volume":"96","author":"S Linder","year":"1999","unstructured":"Linder S, Nelson D, Weiss M, Aepfelbacher M . Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages. Proc Natl Acad Sci USA 1999; 96: 9648\u20139653.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2016366_CR15","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1046\/j.1365-2141.1998.00767.x","volume":"101","author":"D Zicha","year":"1998","unstructured":"Zicha D, Allen WE, Brickell PM, Kinnon C, Dunn GA, Jones GE et al. Chemotaxis of macrophages is abolished in the Wiskott-Aldrich syndrome. Br J Haematol 1998; 101: 659\u2013665.","journal-title":"Br J Haematol"},{"key":"BFonc2016366_CR16","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.4049\/jimmunol.161.2.1026","volume":"161","author":"R Badolato","year":"1998","unstructured":"Badolato R, Sozzani S, Malacarne F, Bresciani S, Fiorini M, Borsatti A et al. Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine. J Immunol 1998; 161: 1026\u20131033.","journal-title":"J Immunol"},{"key":"BFonc2016366_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1083\/jcb.200407076","volume":"168","author":"H Yamaguchi","year":"2005","unstructured":"Yamaguchi H, Lorenz M, Kempiak S, Sarmiento C, Coniglio S, Symons M et al. Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2\/3 complex pathway and cofilin. J Cell Biol 2005; 168: 441\u2013452.","journal-title":"J Cell Biol"},{"key":"BFonc2016366_CR18","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1182\/blood.V97.9.2633","volume":"97","author":"A Oda","year":"2001","unstructured":"Oda A, Ochs HD, Lasky LA, Spencer S, Ozaki K, Fujihara M et al. CrkL is an adapter for Wiskott-Aldrich syndrome protein and Syk. Blood 2001; 97: 2633\u20132639.","journal-title":"Blood"},{"key":"BFonc2016366_CR19","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jaci.2006.02.005","volume":"117","author":"HD Ochs","year":"2006","unstructured":"Ochs HD, Thrasher AJ . The Wiskott-Aldrich syndrome. J Allergy Clin Immunol 2006; 117: 725\u2013738 quiz 39.","journal-title":"J Allergy Clin Immunol"},{"issue":"6 Pt 1","key":"BFonc2016366_CR20","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S0022-3476(05)82002-5","volume":"125","author":"KE Sullivan","year":"1994","unstructured":"Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA . A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 1994; 125 (6 Pt 1): 876\u2013885.","journal-title":"J Pediatr"},{"key":"BFonc2016366_CR21","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0092-8674(00)81050-8","volume":"84","author":"M Symons","year":"1996","unstructured":"Symons M, Derry JM, Karlak B, Jiang S, Lemahieu V, McCormick F et al. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell 1996; 84: 723\u2013734.","journal-title":"Cell"},{"key":"BFonc2016366_CR22","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.1073\/pnas.93.11.5615","volume":"93","author":"R Kolluri","year":"1996","unstructured":"Kolluri R, Tolias KF, Carpenter CL, Rosen FS, Kirchhausen T . Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase Cdc42. Proc Natl Acad Sci USA 1996; 93: 5615\u20135618.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2016366_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/35004513","volume":"404","author":"AS Kim","year":"2000","unstructured":"Kim AS, Kakalis LT, Abdul-Manan N, Liu GA, Rosen MK . Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature 2000; 404: 151\u2013158.","journal-title":"Nature"},{"key":"BFonc2016366_CR24","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood.V93.6.2003.406k13_2003_2012","volume":"93","author":"Y Baba","year":"1999","unstructured":"Baba Y, Nonoyama S, Matsushita M, Yamadori T, Hashimoto S, Imai K et al. Involvement of wiskott-aldrich syndrome protein in B-cell cytoplasmic tyrosine kinase pathway. Blood 1999; 93: 2003\u20132012.","journal-title":"Blood"},{"key":"BFonc2016366_CR25","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/S1097-2765(03)00172-2","volume":"11","author":"GO Cory","year":"2003","unstructured":"Cory GO, Cramer R, Blanchoin L, Ridley AJ . Phosphorylation of the WASP-VCA domain increases its affinity for the Arp2\/3 complex and enhances actin polymerization by WASP. Mol Cell 2003; 11: 1229\u20131239.","journal-title":"Mol Cell"},{"key":"BFonc2016366_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1084\/jem.20030976","volume":"199","author":"K Badour","year":"2004","unstructured":"Badour K, Zhang J, Shi F, Leng Y, Collins M, Siminovitch KA . Fyn and PTP-PEST-mediated regulation of Wiskott-Aldrich syndrome protein (WASp) tyrosine phosphorylation is required for coupling T cell antigen receptor engagement to WASp effector function and T cell activation. J Exp Med 2004; 199: 99\u2013112.","journal-title":"J Exp Med"},{"key":"BFonc2016366_CR27","doi-asserted-by":"publisher","first-page":"14671","DOI":"10.1073\/pnas.94.26.14671","volume":"94","author":"N Ramesh","year":"1997","unstructured":"Ramesh N, Anton IM, Hartwig JH, Geha RS . WIP, a protein associated with wiskott-aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells. Proc Natl Acad Sci USA 1997; 94: 14671\u201314676.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2016366_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0092-8674(02)01076-0","volume":"111","author":"BF Volkman","year":"2002","unstructured":"Volkman BF, Prehoda KE, Scott JA, Peterson FC, Lim WA . Structure of the N-WASP EVH1 domain-WIP complex: insight into the molecular basis of Wiskott-Aldrich Syndrome. Cell 2002; 111: 565\u2013576.","journal-title":"Cell"},{"key":"BFonc2016366_CR29","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.4049\/jimmunol.162.8.5019","volume":"162","author":"DM Stewart","year":"1999","unstructured":"Stewart DM, Tian L, Nelson DL . Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein. J Immunol 1999; 162: 5019\u20135024.","journal-title":"J Immunol"},{"key":"BFonc2016366_CR30","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1073\/pnas.0610275104","volume":"104","author":"MA de la Fuente","year":"2007","unstructured":"de la Fuente MA, Sasahara Y, Calamito M, Anton IM, Elkhal A, Gallego MD et al. WIP is a chaperone for Wiskott-Aldrich syndrome protein (WASP). Proc Natl Acad Sci USA 2007; 104: 926\u2013931.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2016366_CR31","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.devcel.2011.04.007","volume":"20","author":"P Jin","year":"2011","unstructured":"Jin P, Duan R, Luo F, Zhang G, Hong SN, Chen EH . Competition between blown fuse and WASP for WIP binding regulates the dynamics of WASP-dependent actin polymerization in vivo. Dev Cell 2011; 20: 623\u2013638.","journal-title":"Dev Cell"},{"key":"BFonc2016366_CR32","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1038\/onc.2011.542","volume":"31","author":"SR McDonnell","year":"2011","unstructured":"McDonnell SR, Hwang SR, Basrur V, Conlon KP, Fermin D, Wey E et al. NPM-ALK signals through glycogen synthase kinase 3beta to promote oncogenesis. Oncogene 2011; 31: 3733\u20133740.","journal-title":"Oncogene"},{"key":"BFonc2016366_CR33","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.4049\/jimmunol.157.9.3791","volume":"157","author":"GO Cory","year":"1996","unstructured":"Cory GO, MacCarthy-Morrogh L, Banin S, Gout I, Brickell PM, Levinsky RJ et al. Evidence that the Wiskott-Aldrich syndrome protein may be involved in lymphoid cell signaling pathways. J Immunol 1996; 157: 3791\u20133795.","journal-title":"J Immunol"},{"key":"BFonc2016366_CR34","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ng.451","volume":"41","author":"CE Meacham","year":"2009","unstructured":"Meacham CE, Ho EE, Dubrovsky E, Gertler FB, Hemann MT . in vivo RNAi screening identifies regulators of actin dynamics as key determinants of lymphoma progression. Nat Genet 2009; 41: 1133\u20131137.","journal-title":"Nat Genet"},{"key":"BFonc2016366_CR35","doi-asserted-by":"publisher","first-page":"8533","DOI":"10.1021\/bi0472954","volume":"44","author":"A Donella-Deana","year":"2005","unstructured":"Donella-Deana A, Marin O, Cesaro L, Gunby RH, Ferrarese A, Coluccia AM et al. Unique substrate specificity of anaplastic lymphoma kinase (ALK): development of phosphoacceptor peptides for the assay of ALK activity. Biochemistry 2005; 44: 8533\u20138542.","journal-title":"Biochemistry"},{"key":"BFonc2016366_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4161\/cib.3.2.10759","volume":"3","author":"A Dovas","year":"2010","unstructured":"Dovas A, Cox D . Regulation of WASp by phosphorylation: activation or other functions? Commun Integr Biol 2010; 3: 101\u2013105.","journal-title":"Commun Integr Biol"},{"issue":"Pt 3","key":"BFonc2016366_CR37","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1242\/jcs.092726","volume":"125","author":"B Gligorijevic","year":"2012","unstructured":"Gligorijevic B, Wyckoff J, Yamaguchi H, Wang Y, Roussos ET, Condeelis J . N-WASP-mediated invadopodium formation is involved in intravasation and lung metastasis of mammary tumors. J Cell Sci 2012; 125 (Pt 3): 724\u2013734.","journal-title":"J Cell Sci"},{"key":"BFonc2016366_CR38","doi-asserted-by":"publisher","first-page":"6978","DOI":"10.1158\/0008-5472.CAN-10-0861","volume":"70","author":"F Lagarrigue","year":"2010","unstructured":"Lagarrigue F, Dupuis-Coronas S, Ramel D, Delsol G, Tronchere H, Payrastre B et al. Matrix metalloproteinase-9 is upregulated in nucleophosmin-anaplastic lymphoma kinase-positive anaplastic lymphomas and activated at the cell surface by the chaperone heat shock protein 90 to promote cell invasion. Cancer Res 2010; 70: 6978\u20136987.","journal-title":"Cancer Res"},{"key":"BFonc2016366_CR39","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA . Hallmarks of cancer: the next generation. Cell 2011; 144: 646\u2013674.","journal-title":"Cell"},{"key":"BFonc2016366_CR40","first-page":"155","volume":"11","author":"J Lane","year":"2014","unstructured":"Lane J, Martin T, Weeks HP, Jiang WG . Structure and role of WASP and WAVE in Rho GTPase signalling in cancer. Cancer Genomics Proteomics 2014; 11: 155\u2013165.","journal-title":"Cancer Genomics Proteomics"},{"key":"BFonc2016366_CR41","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.ejcb.2012.07.002","volume":"91","author":"C Cougoule","year":"2012","unstructured":"Cougoule C, Van Goethem E, Le Cabec V, Lafouresse F, Dupre L, Mehraj V et al. Blood leukocytes and macrophages of various phenotypes have distinct abilities to form podosomes and to migrate in 3D environments. Eur J Cell Biol 2012; 91: 938\u2013949.","journal-title":"Eur J Cell Biol"},{"key":"BFonc2016366_CR42","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1182\/blood-2002-12-3791","volume":"102","author":"K Wolf","year":"2003","unstructured":"Wolf K, Muller R, Borgmann S, Brocker EB, Friedl P . Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases. Blood 2003; 102: 3262\u20133269.","journal-title":"Blood"},{"key":"BFonc2016366_CR43","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1016\/j.cub.2006.10.037","volume":"16","author":"HC Chou","year":"2006","unstructured":"Chou HC, Anton IM, Holt MR, Curcio C, Lanzardo S, Worth A et al. WIP regulates the stability and localization of WASP to podosomes in migrating dendritic cells. Curr Biol 2006; 16: 2337\u20132344.","journal-title":"Curr Biol"},{"key":"BFonc2016366_CR44","doi-asserted-by":"publisher","first-page":"15738","DOI":"10.1073\/pnas.0904346106","volume":"106","author":"MP Blundell","year":"2009","unstructured":"Blundell MP, Bouma G, Metelo J, Worth A, Calle Y, Cowell LA et al. Phosphorylation of WASp is a key regulator of activity and stability in vivo. Proc Natl Acad Sci USA 2009; 106: 15738\u201315743.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2016366_CR45","doi-asserted-by":"publisher","first-page":"6328","DOI":"10.1021\/jm200758k","volume":"54","author":"GR Ott","year":"2011","unstructured":"Ott GR, Wells GJ, Thieu TV, Quail MR, Lisko JG, Mesaros EF et al. 2,7-Disubstituted-pyrrolo[2,1-f][1,2,4]triazines: new variant of an old template and application to the discovery of anaplastic lymphoma kinase (ALK) inhibitors with in vivo antitumor activity. J Med Chem 2011; 54: 6328\u20136341.","journal-title":"J Med Chem"},{"key":"BFonc2016366_CR46","doi-asserted-by":"publisher","first-page":"7261","DOI":"10.1016\/j.bmcl.2011.10.055","volume":"21","author":"R Tripathy","year":"2011","unstructured":"Tripathy R, McHugh RJ, Ghose AK, Ott GR, Angeles TS, Albom MS et al. Pyrazolone-based anaplastic lymphoma kinase (ALK) inhibitors: control of selectivity by a benzyloxy group. Bioorg Med Chem Lett 2011; 21: 7261\u20137264.","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2016366.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2016366","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2016366.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T09:24:35Z","timestamp":1692523475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2016366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,3]]},"references-count":46,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["BFonc2016366"],"URL":"https:\/\/doi.org\/10.1038\/onc.2016.366","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,3]]},"assertion":[{"value":"7 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}